Caricamento...
Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese
BACKGROUND: Whether rosiglitazone may affect the risk of non-melanoma skin cancer (NMSC) has not been investigated. METHODS: The reimbursement databases of all Taiwanese diabetic patients from 1996 to 2009 were retrieved from the National Health Insurance. An entry date was set at 1 January 2006 and...
Salvato in:
| Pubblicato in: | BMC Cancer |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4325941/ https://ncbi.nlm.nih.gov/pubmed/25655946 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1057-8 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|